Sign in

CIK 0001649989

  • Non-accelerated filer
  • Smaller reporting company

Outlook Therapeutics, Inc.

Sign in to watch
Ticker
OTLK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Sep 30
Incorporated
DE
Entity type
Operating
EIN
383982704
Phone
+1 609-619-3990
Business address
111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
Former names
Oncobiologics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 71 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-04-21 BioLexis Pte Ltd. 10% owner Other disposition −27,982,529 22,982,529
2020-03-23 BioLexis Pte Ltd. Director Exercise or conversion +29,358,621 50,965,058
2020-03-23 BioLexis Pte Ltd. Director Exercise or conversion · Series A-1 Convertible Preferred Stock −68,112 0
2020-03-19 BioLexis Pte Ltd. Director Returned to the company · Series A-1 Convertible Preferred Stock −68,112 0
2020-03-19 BioLexis Pte Ltd. Director Grant or award · Series A-1 Convertible Preferred Stock +68,112 68,112
2020-01-29 BioLexis Pte Ltd. Director Exercise or conversion +4,657,852 $0.23 $1.1M 21,606,437
2020-01-29 BioLexis Pte Ltd. Director Exercise or conversion · Warrant (Right to Buy) −2,093,750 0
2020-01-29 BioLexis Pte Ltd. Director Exercise or conversion · Warrant (Right to Buy) −1,282,051 $1.00 $1.3M 0
2020-01-29 BioLexis Pte Ltd. Director Exercise or conversion · Warrant (Right to Buy) −1,282,051 $1.00 $1.3M 0
2020-01-27 BioLexis Pte Ltd. Director Returned to the company · Warrant (Right to Buy) −2,093,750 0
2020-01-27 BioLexis Pte Ltd. Director Grant or award · Warrant (Right to Buy) +2,093,750 2,039,750
2020-01-27 BioLexis Pte Ltd. Director Returned to the company · Warrant (Right to Buy) −1,282,051 $1.00 $1.3M 0
2020-01-27 BioLexis Pte Ltd. Director Grant or award · Warrant (Right to Buy) +1,282,051 $1.00 $1.3M 1,282,051
2020-01-27 BioLexis Pte Ltd. Director Returned to the company · Warrant (Right to Buy) −1,282,051 $1.00 $1.3M 0
2020-01-27 BioLexis Pte Ltd. Director Grant or award · Warrant (Right to Buy) +1,282,051 $1.00 $1.3M 1,282,051
2019-12-31 BioLexis Pte Ltd. Director Other acquisition · Series A-1 Convertible Preferred Stock +1,661 68,112
2019-12-23 BioLexis Pte Ltd. Director Exercise or conversion +2,909,091 $0.23 $675K 16,948,585
2019-12-23 BioLexis Pte Ltd. Director Exercise or conversion · Warrant (Right to Buy) −3,636,364 0
2019-09-30 BioLexis Pte Ltd. Director Other acquisition · Series A-1 Convertible Preferred Stock +1,620 66,451
2019-06-30 BioLexis Pte Ltd. Director Other acquisition · Series A-1 Convertible Preferred Stock +1,581 64,831

Page 1 of 2 · 27 trades